PM

Paul McKenzie

CSL Limited | Chief Operating Officer, Executive Director, Chief Executive Officer, Managing Director
Dr McKenzie has more than 30 years of leadership experience in the global biotechnology industry, including managing organisations through growth and transformation. He changed CSL's global end to end operations, advanced CSL Seqirus differentiated portfolio strategy, and led CSL Plasma through COVID-19 challenges while surpassing plasma collection volumes beyond pre-pandemic levels. Prior to joining CSL, Dr McKenzie was executive vice president of Pharmaceutical Operations & Technology at Biogen. He also served in a range of progressively senior level roles in R&D and manufacturing at Johnson & Johnson, Bristol-Myers Squibb, and Merck. He is also Member of the Innovation and Development Committee.

Company and Roles

Company
Title
Tenure
Since
CSL
CSL
CSL Limited
  • Chief Operating Officer
  • Executive Director
  • Chief Executive Officer
  • Managing Director
2yrs, 1mthDec 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CSL
CSL
CSL Limited
31/10/24N/A22,952N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CSL
CSL
CSL Limited
31/10/24
Sell
4,000$287.150$1,148,600On-market trade
CSL
CSL
CSL Limited
30/10/24
Issued
38,065$287.460$10,942,164Issue of securities
CSL
CSL
CSL Limited
03/09/24
Sell
3,779$304.313$1,149,997On-market trade
CSL
CSL
CSL Limited
03/09/24
Expiry
10,742$306.030$3,287,374As advised by the company
CSL
CSL
CSL Limited
03/09/24
Buy
8,275$306.030$2,532,398Conversion of securities